Bristol-Myers Squibb buy tamam
Start price
03.01.19
/
50%
€43.41
Target price
04.11.21
€72.00
Performance (%)
17.75%
End price
05.11.21
€51.12
Summary
This prediction ended on 05.11.21 with a price of €51.12. The prediction had a final performance of 17.75%. A total of €4.86 was paid as dividends for this prediction. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | -0.481% | -0.481% | -6.964% | -16.316% |
| iShares Core DAX® | -1.104% | -6.084% | 3.201% | 53.313% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 20.240% | 93.480% |
| iShares Nikkei 225® | -1.082% | -7.987% | 27.550% | 52.317% |
| iShares S&P 500 | -0.055% | 0.880% | 14.887% | 66.737% |
Comments by tamam for this prediction
In the thread Bristol-Myers Squibb diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 03.01.2019 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 59.93$ zu.
Kursziel geändert auf 62,0
Kursziel geändert auf 72,0
In the thread Trading Bristol-Myers Squibb
Die von tamam gewählte maximale Laufzeit wurde überschritten